FdaApplication
NDA 202091
Identifiers
- fda_app_no: NDA202091
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN LTD |
| application_type | NDA |
| approval_date | 2013-02-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUPRAX | CEFIXIME | 500MG/5ML | FOR SUSPENSION;ORAL |
1 product